Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Verisk Analytics
VRSK
|
+$439M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$291M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$260M |
| 4 |
PepsiCo
PEP
|
+$214M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$179M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.18B |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$721M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$429M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$358M |
| 5 |
Microsoft
MSFT
|
+$336M |
Sector Composition
| 1 | Technology | 22.94% |
| 2 | Healthcare | 10.31% |
| 3 | Consumer Discretionary | 9.3% |
| 4 | Financials | 8.85% |
| 5 | Industrials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
EXL Service
EXLS
$7.04B
| $784K | ﹤0.01% |
27,943
-104,432
| -79% | -$2.93M |
|
2002
Medifast
MED
$154M
| $783K | ﹤0.01% |
10,461
-587
| -5% | -$43.9K |
|
2003
Maximus
MMS
$5.05B
| $781K | ﹤0.01% |
10,452
-29,641
| -74% | -$2.21M |
|
2004
NewMarket
NEU
$7.87B
| $780K | ﹤0.01% |
1,715
-1,135
| -40% | -$516K |
|
|
CRESY
2005
Cresud
CRESY
$518M
| $780K | ﹤0.01% |
117,797
+52,180
| +80% | +$346K |
|
2006
WesBanco
WSBC
$3.03B
| $780K | ﹤0.01% |
31,947
-26,168
| -45% | -$639K |
|
2007
PagSeguro Digital
PAGS
$2.78B
| $779K | ﹤0.01% |
90,438
-120,399
| -57% | -$1.04M |
|
2008
ITT
ITT
$13.8B
| $778K | ﹤0.01% |
7,950
-1,500
| -16% | -$147K |
|
2009
FB Financial Corp
FBK
$2.86B
| $777K | ﹤0.01% |
27,398
-15,447
| -36% | -$438K |
|
2010
Anavex Life Sciences
AVXL
$805M
| $776K | ﹤0.01% |
118,446
-5,614
| -5% | -$36.8K |
|
2011
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.81B
| $776K | ﹤0.01% |
19,634
+2,532
| +15% | +$100K |
|
2012
Invesco Large Cap Value ETF
PWV
$1.41B
| $775K | ﹤0.01% |
16,569
-73
| -0.4% | -$3.42K |
|
2013
Supernus Pharmaceuticals
SUPN
$2.55B
| $773K | ﹤0.01% |
28,023
-21,395
| -43% | -$590K |
|
2014
SLM Corp
SLM
$5.86B
| $771K | ﹤0.01% |
56,595
-31,292
| -36% | -$426K |
|
|
DCPH
2015
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $771K | ﹤0.01% |
60,580
-25,943
| -30% | -$330K |
|
2016
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$945M
| $770K | ﹤0.01% |
8,218
+45
| +0.6% | +$4.22K |
|
2017
IAC Inc
IAC
$2.89B
| $770K | ﹤0.01% |
18,634
+1,603
| +9% | +$66.3K |
|
2018
STAAR Surgical
STAA
$1.37B
| $770K | ﹤0.01% |
19,163
+2,434
| +15% | +$97.8K |
|
2019
Brunswick
BC
$4.26B
| $768K | ﹤0.01% |
9,723
+742
| +8% | +$58.6K |
|
2020
Modine Manufacturing
MOD
$7.86B
| $768K | ﹤0.01% |
16,787
-12,652
| -43% | -$579K |
|
2021
Noble Corp
NE
$4.81B
| $765K | ﹤0.01% |
15,097
-34,465
| -70% | -$1.75M |
|
2022
Vishay Intertechnology
VSH
$2.07B
| $762K | ﹤0.01% |
30,830
-60,454
| -66% | -$1.49M |
|
2023
Westlake Chemical Partners
WLKP
$763M
| $762K | ﹤0.01% |
35,038
| – | – |
|
2024
Genmab
GMAB
$17.1B
| $760K | ﹤0.01% |
21,545
+12,863
| +148% | +$454K |
|
2025
First Trust Energy AlphaDEX Fund
FXN
$281M
| $758K | ﹤0.01% |
43,540
-2,109
| -5% | -$36.7K |
|